Chresta, C.M., Davies, B.R., Hickson, I., et al. (2010) AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP- Competitive Mammalian Target of Rapamycin Kinase Inhibitor with in Vitro and in Vivo Antitumor Activity. Cancer Research, 70, 288-298.

相关文章:
在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享